Statistical analysis plan of PROWESS SHOCK study

被引：14

作者：

Thompson, B. Taylor ^{[2
]}

Ranieri, V. Marco ^{[1
]}

Finfer, Simon ^{[3
]}

Barie, Philip S. ^{[4
]}

Dhainaut, Jean-Francois ^{[5
]}

Douglas, Ivor S. ^{[6
,7
]}

Gardlund, Bengt ^{[8
]}

Marshall, John C. ^{[9
]}

Rhodes, Andrew

机构：

[1] Univ Turin, Osped S Giovanni Battista Molinette, Turin, Italy

[2] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA

[3] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia

[4] P713A Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA

[5] Cochin Port Royal Univ, Paris, France

[6] Denver Hlth, Denver, CO USA

[7] Univ Colorado, Denver, CO 80202 USA

[8] Karolinska Univ Hosp, Dept Infect Dis, S-14186 Huddinge, Sweden

[9] St Michaels Hosp, Dept Surg & Crit Care Med, Toronto, ON M5B 1W8, Canada

来源：

INTENSIVE CARE MEDICINE | 2010年 / 36卷 / 11期

关键词：

ACTIVATED PROTEIN-C; TRIAL;

D O I：

10.1007/s00134-010-1977-3

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1972 / 1973

页数：2

共 8 条

[1] Bernard GR, 2007, CRIT CARE MED, V35, pA264
[2] Efficacy and safety of recombinant human activated protein C for severe sepsis.
Bernard, GR
Vincent, JL
Laterre, P
LaRosa, SP
Dhainaut, JF
Lopez-Rodriguez, A
Steingrub, JS
Garber, GE
Helterbrand, JD
Ely, EW
Fisher, CJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
[3] Delaney A, 2008, CRIT CARE, V12, DOI [10.1186/cc6849, 10.1186/cc6576]
[4] Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
Dellinger, R. Phillip
Levy, Mitchell M.
Carlet, Jean M.
Bion, Julian
Parker, Margaret M.
Jaeschke, Roman
Reinhart, Konrad
Angus, Derek C.
Brun-Buisson, Christian
Beale, Richard
Calandra, Thierty
Dhainaut, Jean-Francois
Gerlach, Herwig
Harvey, Maurene
Marini, John J.
Marshall, John
Ranieri, Marco
Ramsay, Graham
Sevransky, Jonathan
Thompson, B. Taylor
Townsend, Sean
Vender, Jeffrey S.
Zimmerman, Janice L.
Vincent, Jean-Louis
[J]. CRITICAL CARE MEDICINE, 2008, 36 (01) : 296 - 327
[5] Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock
Finfer, Simon
Ranieri, V. Marco
Thompson, B. Taylor
Barie, Philip S.
Dhainaut, Jean-Francois
Douglas, Ivor S.
Gardlund, Bengt
Marshall, John C.
Rhodes, Andrew
[J]. INTENSIVE CARE MEDICINE, 2008, 34 (11) : 1935 - 1947
[6] Finfer S, 2009, CRIT CARE RESUSC, V11, P5
[7] The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
Levy, Mitchell M.
Dellinger, R. Phillip
Townsend, Sean R.
Linde-Zwirble, Walter T.
Marshall, John C.
Bion, Julian
Schorr, Christa
Artigas, Antonio
Ramsay, Graham
Beale, Richard
Parker, Margaret M.
Gerlach, Herwig
Reinhart, Konrad
Silva, Eliezer
Harvey, Maurene
Regan, Susan
Angus, Derek C.
[J]. INTENSIVE CARE MEDICINE, 2010, 36 (02) : 222 - 231
[8] Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis
Tidswell, Mark
Tillis, William
LaRosa, Steven P.
Lynn, Melvyn
Wittek, Alec E.
Kao, Richard
Wheeler, Janice
Gogate, Jagadish
Opal, Steven M.
[J]. CRITICAL CARE MEDICINE, 2010, 38 (01) : 72 - 83

← 1 →